A shadow economy for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.
Separately, a flourishing market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.
Several experts stated the demand for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.
Based on TikTok, the service has taken down problematic content and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of entering one community, a vendor shared contact information, where the majority of purchases take place. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, health issues or past usage.
Inside these groups, messages show black plastic packages with postal service labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When asked how long a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
A spokesperson for Telegram stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her team has already seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational substance not yet approved … may expose users to potentially serious medical dangers”.
